Gyre Therapeutics, Inc. (GYRE) Capital expenditures 2016–2025
Gyre Therapeutics, Inc. (GYRE) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.2MFY2025 · since FY2016: $468,000 → $1.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.2M | -48.6% |
| FY2024 | $2.3M | -72.8% |
| FY2023 | $8.5M | +70.9% |
| FY2022 | $5.0M | +494.2% |
| FY2021 | $839,000 | — |
| FY2019 | $64,000 | -83.0% |
| FY2018 | $376,000 | +1534.8% |
| FY2017 | $23,000 | -95.1% |
| FY2016 | $468,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice